Overview

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics,...

Open

$0.00

Prior close

$18.62

Today's high

$0.00

Today's low

$0.00

52 Week high

$24.68

52 Week low

$14.68

News

Zacks Investment Research • 4 days ago • SRPT

Sarepta Therapeutics (SRPT) Earnings Expected to Grow: Should You Buy?

Business Wire • 7 days ago • SRPT

Sarepta Therapeutics to Present at Upcoming Investor Conferences

Business Wire • 20 days ago • SRPT

Sarepta Therapeutics Presents New Preclinical Data Demonstrating Robust Knockdown of Pathogenic DMPK RNA in the Nucleus with SRP-1003 in DM1 at 2026 Oligonucleotide Therapeutics Society Annual Meeting

Business Wire • about 1 month ago • SRPT

Sarepta Therapeutics Announces Presentations at 2026 World Muscle Society Annual Congress

Business Wire • about 1 month ago • SRPT

Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 27th Annual Neuromuscular Study Group Scientific Meeting